Monday, April 24, 2017

Sun Pharma gets fresh 11 observations from US FDA

pharmabiz.com-15 hours ago
Sun Pharmaceuticals, a Rs. 27,700 crore plus leading Indian pharma entity, has received yet another blow from US FDA. The company's Dadra facility ...
Post a Comment